Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141603 |
| CAS No | NA |
| Mol.F. | C13H10ClFN2O3 |
| Mol.Wt. | 296.68 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141604 |
| CAS No | NA |
| Mol.F. | C17H12D3FN4O3S |
| Mol.Wt. | 377.41 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141605 |
| CAS No | NA |
| Mol.F. | C18H24N6O6S |
| Mol.Wt. | 452.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141606 |
| CAS No | NA |
| Mol.F. | C23H27BrN8O5S |
| Mol.Wt. | 607.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141607 |
| CAS No | NA |
| Mol.F. | C23H27ClN8O7S |
| Mol.Wt. | 595 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141608 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O5S |
| Mol.Wt. | 549 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141609 |
| CAS No | NA |
| Mol.F. | C22H24ClN7O6S |
| Mol.Wt. | 550 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141610 |
| CAS No | NA |
| Mol.F. | C23H27ClN8O5S |
| Mol.Wt. | 563 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141611 |
| CAS No | NA |
| Mol.F. | C23H27ClN8O5S |
| Mol.Wt. | 563 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141612 |
| CAS No | NA |
| Mol.F. | C23H27ClN8O5S |
| Mol.Wt. | 563 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141613 |
| CAS No | NA |
| Mol.F. | C23H27ClN8O6S |
| Mol.Wt. | 579 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141614 |
| CAS No | NA |
| Mol.F. | C23H27BrN8O5S |
| Mol.Wt. | 607.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141615 |
| CAS No | NA |
| Mol.F. | C12H13N3O3 |
| Mol.Wt. | 247.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141616 |
| CAS No | NA |
| Mol.F. | C20H17N3O5 |
| Mol.Wt. | 379.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141617 |
| CAS No | NA |
| Mol.F. | C20H16N4O6 |
| Mol.Wt. | 408.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141618 |
| CAS No | NA |
| Mol.F. | C19H15N3O5 |
| Mol.Wt. | 365.3 |
| INV STATUS | CUSTOM SYNTHESIS |